Chinese FDA Shows Signs Of Loosening Up, Say Pharmaceutical Sector Leaders
This article was originally published in PharmAsia News
Executive Summary
SAN FRANCISCO - Roche will try to test a foreign-discovered drug in a first-in-man clinical trial in China in the next two years, according to one of the firm's top R&D officials in that country. The move would mark a huge shift in attitude at China's pharmaceutical regulatory agency, which to date only allows in-country discoveries to move into Chinese first-in-man clinical trials